Get startedLog in
    Picture of Jazz Pharmaceuticals logo

    JAZZ — Jazz Pharmaceuticals Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Jazz Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line239-330-224415560
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items605311876352461
    Unusual Items
    Purchased R&D
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-85.4175283-53-76.7
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Cash from Operating Activities9007791,2721,0921,396
    Capital Expenditures-379-45.5-498-43-48.1
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-628-5,16752-120-460
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Change in Net Investments
    Purchase of Investments
    Cash from Investing Activities-1,008-5,212-446-163-508
    Financing Cash Flow Items-16.9-35.6-45.4-51-63.5
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities5283,971-529-30520.5
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash420-466290625907